7 results match your criteria: "Hospital Vega Baja-FISABIO[Affiliation]"

We conducted a multicentre observational study in people living with HIV (PLHIV) on antiretroviral therapy in Alicante (Spain) from 2019 to 2020 aiming to analyse the prevalence of abuse and assess treatment adherence according to this variable. We used the Abuse Assessment Screen tool, the simplified medication adherence questionnaire and the medication possession ratio to assess outcomes..

View Article and Find Full Text PDF

Comments to the document GEPI-SEIMC screening recommendations for patients with suspected strongyloidosis.

Enferm Infecc Microbiol Clin (Engl Ed)

August 2022

Servicio de Medicina Interna/infecciosas, Hospital Vega Baja-FISABIO, Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández de Elche, San Juan de Alicante, Spain.

View Article and Find Full Text PDF

A Review on Strongyloidiasis in Pregnant Women.

Res Rep Trop Med

September 2021

Internal Medicine and Infectious Diseases Department, Hospital Vega Baja-FISABIO, Alicante, Spain.

Strongyloidiasis is a parasitic infection distributed worldwide, with an estimated 614 million people infected. Strongyloidiasis usually presents asymptomatically or with aspecific and mild clinical symptoms, mainly cutaneous, respiratory, or gastrointestinal. Disseminated disease and hyperinfection syndrome are the most serious complications, have a high mortality rate, usually occur in immunosuppressed patients, and are particularly associated with the use of corticosteroids.

View Article and Find Full Text PDF

Impact of the COVID-19 pandemic on tuberculosis management in Spain.

Int J Infect Dis

July 2021

Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain; Mycobacteria Infection Study Group (GEIM, Spanish acronym) from Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC, Spanish acronym), Spain.

Background: The impact of COVID-19 on the diagnosis and management of tuberculosis (TB) patients is unknown.

Methods: Participating centres completed a structured web-based survey regarding changes to TB patient management during the COVID-19 pandemic. The study also included data from participating centres on patients aged ≥18 diagnosed with TB in 2 periods: March 15 to June 30, 2020 and March 15 to June 30, 2019.

View Article and Find Full Text PDF

Background: The best strategy for controlling morbidity due to imported strongyloidiasis in migrants is unclear. We evaluate the cost-effectiveness of six possible interventions.

Methods: We developed a stochastic Markov chain model.

View Article and Find Full Text PDF